Rare diseases
Investigational molecules
Locations
Back to Hungary110 clinical trials in Gyongyos, Hungary across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study of LY4268989 adipic acid in adults with moderately to severely active ulcerative colitis
HungaryPhase III Randomized Study of Rilvegostomig vs. Pembrolizumab with Platinum-based Chemotherapy in PD-L1 Expressing Metastatic Squamous NSCLC
HungaryStudy of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk
HungaryA study testing xanomeline tartrate and trospium chloride for treating agitation in patients with Alzheimer's disease
HungaryStudy of trospium chloride and xanomeline tartrate combination for agitation in Alzheimer's disease patients: Long-term safety evaluation
HungaryStudy of tulisokibart compared to placebo in adults with moderate to severe Crohn's disease
HungaryStudy of RO7790121 (afimkibart) for Treatment and Long-term Management in Adults with Moderate to Severe Crohn's Disease
HungaryStudy on Eltrekibart and Mirikizumab for Adults with Moderate to Severe Ulcerative Colitis
HungaryStudy comparing rilvegostomig plus chemotherapy versus pembrolizumab plus chemotherapy for first-line treatment in patients with metastatic non-squamous lung cancer with PD-L1 expression
HungaryStudy on the Effects of MORF-057 for Adults with Moderate to Severe Crohn's Disease
HungaryStudy on the Effects of Budesonide, Glycopyrronium, and Formoterol Fumarate for Patients with Chronic Obstructive Pulmonary Disease (COPD)
HungaryStudy on the Long-term Safety and Efficacy of Pembrolizumab and Lenvatinib for Patients with Advanced Tumors
HungaryThe busiest research cities in the country
What the registry says about research in the country
Research focusing on innovative treatments for non-small cell lung cancer (NSCLC) and chronic respiratory conditions, with multiple trials evaluating new immunotherapy combinations and targeted therapies.
Several trials are exploring combination therapies to improve patient outcomes in advanced stages of lung cancer.
Comprehensive studies on inflammatory and autoimmune disorders, including psoriasis and inflammatory bowel diseases, testing novel therapeutic approaches.
Multiple trials are evaluating new biological therapies for moderate to severe cases of these conditions.
Innovative studies targeting heart failure prevention and cardiovascular disease management, with a focus on reducing major adverse cardiac events.
Research includes novel therapeutic combinations and preventive strategies for high-risk patients.
Clinical research focusing on Alzheimer's Disease and associated conditions, particularly investigating treatments for psychosis symptoms.
Trials are evaluating new therapeutic approaches for managing neuropsychiatric symptoms.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
